BioVie Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
BioVie Inc. (BIVI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 516.58 million shares for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2019-11-19
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 516.58M shares, a 67.03% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 329.06M shares, a 235.82% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 316.42M shares, a 226.41% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-12-31 was 315.05M shares, a 232.16% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 317.45M shares, a 231.51% increase from fiscal 2018.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 95.76M shares, a 7.12% increase from fiscal 2017.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 89.39M shares, a 2.51% increase from fiscal 2016.
- BioVie Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 87.20M shares, a 0.01% decline from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-09-30 | 516.58M shares 10-Q · filed 2019-11-19 | 422.82M shares derived: average of 2 quarters · filed 2019-11-19 | 387.35M shares derived: average of 3 quarters · filed 2019-11-19 | 369.28M shares derived: average of 4 quarters · filed 2019-11-19 |
| 2019-06-30 | 329.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | 322.74M shares derived: average of 2 quarters · filed 2019-09-27 | 320.18M shares derived: average of 3 quarters · filed 2019-09-27 | 317.45M shares 10-K · filed 2019-09-27 |
| 2019-03-31 | 316.42M shares 10-Q · filed 2019-05-10 | 315.74M shares derived: average of 2 quarters · filed 2019-05-10 | 313.58M shares 10-Q · filed 2019-05-10 | 259.69M shares derived: average of 4 quarters · filed 2019-11-19 |
| 2018-12-31 | 315.05M shares 10-Q · filed 2019-02-12 | 312.18M shares 10-Q · filed 2019-02-12 | 240.77M shares derived: average of 3 quarters · filed 2019-11-19 | 204.82M shares derived: average of 4 quarters · filed 2019-11-19 |
| 2018-09-30 | 309.28M shares 10-Q · filed 2019-11-19 | 203.63M shares derived: average of 2 quarters · filed 2019-11-19 | 168.07M shares derived: average of 3 quarters · filed 2019-11-19 | 149.76M shares derived: average of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | 97.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | 97.46M shares derived: average of 2 quarters · filed 2019-09-27 | 96.59M shares derived: average of 3 quarters · filed 2019-09-27 | 95.76M shares 10-K · filed 2019-09-27 |
| 2018-03-31 | 96.94M shares 10-Q · filed 2019-05-10 | 95.89M shares derived: average of 2 quarters · filed 2019-05-10 | 95.01M shares 10-Q · filed 2019-05-10 | 94.22M shares derived: average of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | 94.85M shares 10-Q · filed 2019-02-12 | 94.08M shares 10-Q · filed 2019-02-12 | 93.31M shares derived: average of 3 quarters · filed 2019-02-12 | 92.86M shares derived: average of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | 93.30M shares 10-Q · filed 2018-11-14 | 92.55M shares derived: average of 2 quarters · filed 2018-11-14 | 92.19M shares derived: average of 3 quarters · filed 2018-11-14 | 91.02M shares derived: average of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | 91.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | 91.64M shares derived: average of 2 quarters · filed 2018-10-05 | 90.26M shares derived: average of 3 quarters · filed 2018-10-05 | 89.39M shares 10-K · filed 2018-10-05 |
| 2017-03-31 | 91.49M shares 10-Q · filed 2018-05-14 | 89.50M shares derived: average of 2 quarters · filed 2018-05-14 | 88.59M shares 10-Q · filed 2018-05-14 | 88.34M shares derived: average of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | 87.50M shares 10-Q · filed 2018-02-14 | 87.36M shares 10-Q · filed 2018-02-14 | 87.29M shares derived: average of 3 quarters · filed 2018-02-14 | 87.27M shares derived: average of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | 87.21M shares 10-Q · filed 2017-11-08 | 87.19M shares derived: average of 2 quarters · filed 2017-11-08 | 87.19M shares derived: average of 3 quarters · filed 2017-11-08 | 87.20M shares derived: average of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | 87.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | 87.19M shares derived: average of 2 quarters · filed 2017-08-24 | 87.20M shares derived: average of 3 quarters · filed 2017-08-24 | 87.20M shares 10-K · filed 2017-08-24 |
| 2016-03-31 | 87.21M shares 10-Q · filed 2017-05-09 | 87.21M shares derived: average of 2 quarters · filed 2017-05-09 | 87.21M shares 10-Q · filed 2017-05-09 | 87.21M shares derived: average of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | 87.21M shares 10-Q · filed 2017-02-07 | 87.21M shares 10-Q · filed 2017-02-07 | 87.21M shares derived: average of 3 quarters · filed 2017-02-07 | 87.21M shares derived: average of 4 quarters · filed 2017-02-07 |
| 2015-09-30 | 87.21M shares 10-Q/A · filed 2017-01-19 | 87.21M shares derived: average of 2 quarters · filed 2017-01-19 | 87.21M shares derived: average of 3 quarters · filed 2017-01-19 | 87.21M shares derived: average of 4 quarters · filed 2017-01-19 |
| 2015-06-30 | 87.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | 87.21M shares derived: average of 2 quarters · filed 2016-09-28 | 87.21M shares derived: average of 3 quarters · filed 2016-09-28 | 87.21M shares 10-K · filed 2016-09-28 |
| 2015-03-31 | 87.21M shares 10-Q · filed 2016-05-23 | 87.21M shares derived: average of 2 quarters · filed 2016-05-23 | 87.21M shares 10-Q · filed 2016-05-23 | 87.19M shares derived: average of 4 quarters · filed 2016-05-23 |
| 2014-12-31 | 87.21M shares 10-Q · filed 2016-02-16 | 87.21M shares 10-Q · filed 2016-02-16 | 87.18M shares derived: average of 3 quarters · filed 2016-02-16 | 87.16M shares derived: average of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | 87.21M shares 10-Q · filed 2015-11-13 | 87.17M shares derived: average of 2 quarters · filed 2015-11-13 | 87.14M shares derived: average of 3 quarters · filed 2015-11-13 | 87.12M shares derived: average of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | 87.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-01 | 87.11M shares derived: average of 2 quarters · filed 2015-10-01 | 87.09M shares derived: average of 3 quarters · filed 2015-10-01 | 87.08M shares 10-K · filed 2015-10-01 |
| 2014-03-31 | 87.08M shares 10-Q · filed 2015-05-11 | 87.07M shares derived: average of 2 quarters · filed 2015-05-11 | 87.07M shares 10-Q · filed 2015-05-11 | 76.61M shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 87.06M shares 10-Q · filed 2015-02-05 | 87.06M shares 10-Q · filed 2015-02-05 | 73.05M shares 10-Q · filed 2014-01-29 | |
| 2013-09-30 | 87.06M shares 10-Q · filed 2014-11-13 | 65.60M shares 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | 41.23M shares 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |